<DOC>
	<DOCNO>NCT01428180</DOCNO>
	<brief_summary>The purpose study examine influence medical surgical treatment patent ductus arteriosus preterm infant cerebral renal tissue oxygenation cardiac output .</brief_summary>
	<brief_title>Influence Treatment Patent Ductus Arteriosus Cerebral Oxygenation Preterm Infants</brief_title>
	<detailed_description>In observational trial investigator want examine whether clinical echocardiographic parameter patent ductus arteriosus relate - cerebral tissue oxygen saturation , total hemoglobin , fractional tissue oxygen extraction HbD - renal tissue oxygen saturation , total hemoglobin , fractional tissue oxygen extraction HbD measure near infrared spectroscopy - stroke volume - cardiac output measure electrical cardiometry . The investigator want examine impact surgical medical treatment patent ductus parameter . The investigator want compare change parameter responder medical treatment nonresponders .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Newborn infant 34 week postmenstrual age time birth Patent ductus arteriosus sign hemodynamic relevance ( judged attend neonatologist ) parental informed consent Patent ductus arteriosus part malformation syndrome Additional major cardiovascular malformation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>34 Weeks</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>preterm neonate</keyword>
	<keyword>hemodynamically relevant patent ductus arteriosus</keyword>
</DOC>